How did research article publications on the COVID-19 pandemic progress in the Q1 ranked SCImage index journals in 2020?

Abstract

Aim: The aim of this paper is to survey the COVID-19 research articles in Q1 ranked high SJR index journals according to the SCImago journal rank indicator. Material and Method: The study was carried out on the website named "https://www.scimagojr.com". The search was conducted by selecting the criteria “medicine”, “pathology and forensic medicine”, “all regions/countries”, “journals”, and the “2020” as the year. Only 50 scientific journals met these criteria. COVID-19-related and unrelated research articles published in these journals were manually scanned. Review articles, book reviews, conferences, commentaries, case reports, mini reviews, short communications, letters to the editor were not included in the study. COVID-19 related research articles were divided into groups in terms of antemortem and postmortem type of the study by reviewing the abstract of the studies and also grouped according to the country of first author and countries of all authors. Results: A total of 3906 research articles published in 50 journals with Q1 SJR index over 0.887 were investigated. Of these 3906 research articles, 40 of them were related to COVID-19. 31 of these 40 COVID-19 related research articles were antemortem and 9 were postmortem studies. Among these 40 COVID-19 related scientific articles, the first author of publications belonged to 12 countries. United States, Australia, China, and Italy were found to be the most productive countries for published research articles on COVID-19 in selected high SJR index journals. The United States was the country with the highest number of first authors with 15 articles. China was the country with the highest number of multinational author list research articles. Conclusion: We believe that the number and content of studies conducted in these high-quality scientific journals on COVID-19 make important contributions and understanding in the fields of disease transmission, disease prevention, course and severity of symptoms, pathophysiology, molecular characteristics, and treatment approach processes.

Keywords

• COVID-19
• SARS-CoV-2
• publications
• SCImage index

References

1. Worldometers (2021). COVID-19 coronavirus pandemic [Online]. Website: www.worldometers.info/coronavirus/ [Accessed 17 08 2021].
2. Tanoglu EG, Esen MF. Evaluation of studies on molecular biology and genetics related to COVID-19 with data mining. J Health Sci Med 2021; 4: 960-6.
3. Inanc IH, Bursa N, Gültepe A, Sabanoglu C. The impact of COVID-19 on rural population: A retrospective study. J Health Sci Med 2021; 4: 722-7.
4. Menter T, Haslbauer JD, Nienhold R, et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology 2020; 77: 198-209.
5. Ciftciler R, Haznedaroglu IC, Tufan A, Oztürk MA. Covid-19 scientific publications from Turkey. Turk J Med Sci 2021; 51: 877-89.
6. Das T, Bugra A, Arslan MN, Ziyade N, Buyuk Y. Evaluation of postmortem pathological changes in the lung in SARS-CoV-2 RT-PCR positive cases. J Surg Med 2021; 5: 1113-20.
7. Satturwar S, Fowkes M, Farver C, et al. Postmortem findings associated with SARS-CoV-2: systematic review and meta-analysis. Am J Surg Pathol 2021; 45: 587-603.
8. Martines RB, Ritter JM, Matkovic E, et al. Pathology and pathogenesis of SARS-CoV-2 associated with fatal coronavirus disease, United States. Emerg Infect Dis 2020; 26: 2005-15.

9. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579: 270-3.
10. Bryce C, Grimes Z, Pujadas E, et al. Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience. Mod Pathol 2021; 34: 1456–67.
11. Alshammary AF, Al-Sulaiman AM. The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences. Virulence 2021; 12: 1771-94.
12. Khan M, Adil SF, Alkhathlan HZ, et al. COVID-19: a global challenge with old history, epidemiology and progress so far. Molecules 2020; 26: 39.
13. Adil MT, Rahman R, Whitelaw D, et al. SARS-CoV-2 and the pandemic of COVID-19. Postgrad Med J 2021; 97: 110-6.
14. James N, Menzies M. Trends in COVID-19 prevalence and mortality: A year in review. Physica D 2021; 425: 132968.
15. Tang YW, Schmitz JE, Persing DH, Stratton CW. Laboratory diagnosis of COVID-19: current issues and challenges. J Clin Microbiol 2020; 58: e00512-20.
16. Garg A, Ghoshal U, Patel SS, et al. Evaluation of seven commercial RT-PCR kits for COVID-19 testing in pooled clinical specimens. J Med Virol 2021; 93: 2281-6.
17. Tianyu Z, Liying G. Identifying the molecular targets and mechanisms of xuebijing injection for the treatment of COVID-19 via network parmacology and molecular docking. Bioengineered 2021; 12: 2274-87.
18. de Jesus SF, Santos LI, Rodrigues Neto JF, et al. Therapeutic perceptions in antisense RNA- mediated gene regulation for COVID-19. Gene 2021; 800: 145839.
19. Rödel J, Egerer R, Suleyman A, et al. Use of the variplex™ SARS-CoV-2 RT-LAMP as a rapid molecular assay to complement RT-PCR for COVID-19 diagnosis. J Clin Virol 2020; 132: 104616.
20. Iserson KV. SARS-CoV-2 (COVID-19) vaccine development and production: an ethical way forward. Camb Q Healthc Ethics 2021; 30: 59-68.
21. Xiong D, Dai W, Gong J, et al. Rapid detection of SARS-CoV-2 with CRISPR-Cas12a. PLoS Biol 2020; 18: e3000978.
22. Anderson EJ, Campbell JD, Creech CB, et al. Warp speed for coronavirus disease 2019 (COVID-19) vaccines: why are children stuck in neutral? Clin Infect Dis 2021; 73: 336-40.
23. Santana MF, Pivoto G, Alexandre MAA, et al. Confirmed invasive pulmonary aspergillosis and COVID-19: the value of postmortem findings to support antemortem management. Rev Soc Bras Med Trop 2020; 53: e20200401.
24. Gagiannis D, Umathum VG, Bloch W, et al. Antemortem vs postmortem histopathologic and ultrastructural findings in paired transbronchial biopsy specimens and lung autopsy samples from three patients with confirmed SARS-CoV-2. Am J Clin Pathol 2021; aqab087.
25. Chew NWS, Lee GKH, Tan BYQ, et al. A multinational, multicentre study on the psychological outcomes and associated physical symptoms amongst healthcare workers during COVID-19 outbreak. Brain Behav Immun 2020; 88: 559-65.
26. Antúnez-Montes OY, Escamilla MI, Figueroa-Uribe AF, et al. COVID-19 and multisystem inflammatory syndrome in latin american children: a multinational study. Pediatr Infect Dis J 2021; 40: e1-e6.
27. Ceulemans M, Foulon V, Ngo E, et al. Mental health status of pregnant and breastfeeding women during the COVID-19 pandemic-A multinational cross-sectional study. Acta Obstet Gynecol Scand 2021; 100: 1219-29.
28. Şenel E, Topal FE. Holistic analysis of coronavirus literature: a scientometric study of the global publications relevant to SARS-CoV-2 (COVID-19), MERS-CoV (MERS) and SARS-CoV (SARS). Disaster Med Public Health Prep 2020; 1-8.
29. Zdravkovic M, Berger-Estilita J, Zdravkovic B, Berger D. Scientific quality of COVID-19 and SARS CoV-2 publications in the highest impact medical journals during the early phase of the pandemic: A case control study. PLoS One 2020; 15: e0241826. Erratum in: PLoS One 2021; 16: e0250141.
30. Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019- nCoV infection from an asymptomatic contact in Germany. N Eng J Med 2020; 382: 970–1.
31. Mehra MR, Ruschitzka F, Patel AN. Retraction—hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet 2020; 395: 1820.
32. Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Retraction: cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med 2020; 382: 2582.
33. N VR, Patil SB. Indian Publications on SARS-CoV-2: A bibliometric study of WHO COVID-19 database. Diabetes Metab Syndr 2020; 14: 1171-8